CANTHARIDIN
UNII IGL471WQ8P

Substance Identification & Data

This profile provides standardized clinical and technical data for Cantharidin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) IGL471WQ8P.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 56-25-7 and the RxNorm Concept ID (RxCUI) 1984. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

IGL471WQ8P

CAS Registry Number

56-25-7

RxNorm Concept ID

1984

Detailed Substance Profile

Preferred Name

CANTHARIDIN

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

IGL471WQ8P

The specific atomic composition represented as a molecular structure string.

InChIKey

C10H12O4

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

DHZBEENLJMYSHQ-XCVPVQRUSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C177086

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

5944

Unique identification number in the NCBI database of chemical substances.

INN ID

11470

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

GH-82

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@@]12([C@](C(=O)OC1=O)([C@@H]3O[C@H]2CC3)C)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cantharidin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.